Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities

BACKGROUND: Subclassification of ovarian carcinomas can be used to guide treatment and determine prognosis. Germline and somatic mutations, loss of heterozygosity (LOH), and epigenetic events such as promoter hypermethylation can lead to decreased expression of BRCA1/2 in ovarian cancers. The mechan...

Descripción completa

Detalles Bibliográficos
Autores principales: Press, Joshua Z, De Luca, Alessandro, Boyd, Niki, Young, Sean, Troussard, Armelle, Ridge, Yolanda, Kaurah, Pardeep, Kalloger, Steve E, Blood, Katherine A, Smith, Margaret, Spellman, Paul T, Wang, Yuker, Miller, Dianne M, Horsman, Doug, Faham, Malek, Gilks, C Blake, Gray, Joe, Huntsman, David G
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2245962/
https://www.ncbi.nlm.nih.gov/pubmed/18208621
http://dx.doi.org/10.1186/1471-2407-8-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2245962/
https://www.ncbi.nlm.nih.gov/pubmed/18208621
http://dx.doi.org/10.1186/1471-2407-8-17

Ejemplares similares